Psoriatic Arthritis

Latest News

Use of DAPSA28 for Assessment of Disease Activity in Psoriatic Arthritis

Use of DAPSA28 for Assessment of Disease Activity in Psoriatic Arthritis

Investigators sought to determine the validity of using a simplified scoring tool that assesses 28 joint counts compared with the original 66/68 joint counts in patients with psoriatic arthritis.

PsA Activity During and After Pregnancy Affected by Biologic Therapy

PsA Activity During and After Pregnancy Affected by Biologic Therapy

Investigators explore the impact of pregnancy on PsA disease activity, as well as the effect of biologic therapy on PsA disease activity during and following pregnancy.

Risk for Type 2 Diabetes, Cardiovascular Disease Elevated in Patients With Psoriatic Arthritis

Risk for Type 2 Diabetes, Cardiovascular Disease Elevated in Patients With Psoriatic Arthritis

Risk for type 2 diabetes, ischemic heart disease, and peripheral vascular disease was elevated among patients with psoriatic arthritis compared with the general population.

Sustained Improvements in PsA With Certolizumab Pegol Monotherapy, DMARD Combination

Sustained Improvements in PsA With Certolizumab Pegol Monotherapy, DMARD Combination

Results from the RAPID-PsA study showed that patients with PsA who are treated with certolizumab pegol sustained improvements over the course of 4 years when it is taken as a monotherapy or concomitant with DMARDs.

Incidence, Predictors of Orthopedic Surgery in Psoriatic Arthritis

Incidence, Predictors of Orthopedic Surgery in Psoriatic Arthritis

Researchers quantified the incidence of orthopedic procedures in patients with psoriatic arthritis.

Effects of Age, Disease Duration on Bone Erosions in Psoriasis, Psoriatic Arthritis

Effects of Age, Disease Duration on Bone Erosions in Psoriasis, Psoriatic Arthritis

Data show that psoriatic arthritis acts as a strong enhancer of age-related catabolic bone damage.

Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis

Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis

Rheumatologist-assessed inflammatory back pain (IBP) or the criteria for IBP developed for ankylosing spondylitis might not perform well when determining axial involvement in psoriatic arthritis.

Assessing Disease Activity During, After Pregnancy in Psoriatic Arthritis

Assessing Disease Activity During, After Pregnancy in Psoriatic Arthritis

Disease activity was altogether low and stable from preconception to 1 year postpartum among pregnant women with psoriatic arthritis.

Ixekizumab Demonstrates No New Safety Concerns for Treatment of Psoriatic Arthritis

Ixekizumab Demonstrates No New Safety Concerns for Treatment of Psoriatic Arthritis

The safety profile of ixekizumab in the treatment of psoriatic arthritis is similar to the safety profile observed with ixekizumab for the treatment of plaque psoriasis.

Sustained Minimal Disease Activity in Psoriatic Arthritis Prevents Progression of Atherosclerosis

Sustained Minimal Disease Activity in Psoriatic Arthritis Prevents Progression of Atherosclerosis

Sustained minimal disease activity should be maintained for a prolonged period in order to prevent progression of carotid atherosclerosis and arterial stiffness in patients with PsA.

Sign Up for Free e-newsletters